Pharmafile Logo

Gelesis

- PMLiVE

GSK: We had a social responsibility to work on Ebola

And company says it delayed more commercialprojects to do so

- PMLiVE

GSK and Lilly invest in $100m global Dementia Discovery Fund

Fund announced at WHO conference by UK health secretary Jeremy Hunt

- PMLiVE

GSK sells another chunk of South Africa’s Aspen

Paid $418m for an 18% share in Aspen in 2009

Choices, choices: the rapidly evolving HIV treatment landscape

The treatment options for HIV in Europe has seen some revolutionary changes

- PMLiVE

GSK fires Chinese staff over corruption charges

110 employees reportedly dismissed for misconduct

- PMLiVE

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year

Ex Sanofi boss joins Boston start-up

Chris Viehbacher joins other industry veterans as the newest board member of PureTech

- PMLiVE

Novartis and GSK complete oncology and vaccines swap

Follows Swiss company's decision to divest its BRAF and MEK inhibitors to Array BioPharma

- PMLiVE

GSK replaces head of US operations

Deidre Connelly to be replaced by Jack Bailey

- PMLiVE

GSK buys vaccine specialist GlycoVaxyn for $190m

Acquisition will expand GSK’s early vaccines pipeline

- PMLiVE

GSK sees COPD future in triple therapy

High hopes for once a day single inhaler

- PMLiVE

GSK hints at more restructuring following income drop

Company experiences a tough 2014 with Advair competition and China bribery scandal

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links